Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
76
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0991
TP10-2
AGYLLGKINLKPLAALAKKIL-NH2
Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2
NA
NA
NA
21
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
14.71%
Direct iodination
26465925
b3pdb_0992
TP10-2
AGYLLGKINLKPLAALAKKIL-NH2
Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2
NA
NA
NA
21
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
84.29%
Direct iodination
26465925
b3pdb_0993
TP10-2
AGYLLGKINLKPLAALAKKIL-NH2
Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2
NA
NA
NA
21
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.000359 mL/(g x min)
Direct iodination
26465925
b3pdb_0994
TP10-2
AGYLLGKINLKPLAALAKKIL-NH2
Ala-Gly-Tyr-Leu-Leu-Gly-Lys-Ile-Asn-Leu-Lys-Pro-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2
NA
NA
NA
21
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01007 ml/g
Direct iodination
26465925
b3pdb_1088
Ziconotide, SNX-111,
CKGKGAKCSRLMYDCCTGSCRSGKC
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys
NA
NA
Cys1-Cys16; Cys8-Cys20; Cys15-Cys25
25
Linear
NA
Chemically synthesized
C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant
0.0042 mL/(g x min)
Direct iodination
10822104
b3pdb_1089
Ziconotide, SNX-111,
CKGKGAKCSRLMYDCCTGSCRSGKC
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys
NA
NA
Cys1-Cys16; Cys8-Cys20; Cys15-Cys25
25
Linear
NA
Chemically synthesized
C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Initial distribution vaolume
0.0018 ml/g
Direct iodination
10822104
b3pdb_1090
Ziconotide, SNX-111,
CKGKGAKCSRLMYDCCTGSCRSGKC
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys
NA
NA
Cys1-Cys16; Cys8-Cys20; Cys15-Cys25
25
Linear
NA
Chemically synthesized
C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Rpellet
1.31%
Direct iodination
10822104
b3pdb_1091
Ziconotide, SNX-111,
CKGKGAKCSRLMYDCCTGSCRSGKC
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys
NA
NA
Cys1-Cys16; Cys8-Cys20; Cys15-Cys25
25
Linear
NA
Chemically synthesized
C[C@H]1C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3)CO)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Rsupernatant
5.58%
Direct iodination
10822104
b3pdb_1092
SNX-194
CKGKGAKCSRL-Nle-YDCCTGSCRSGKC
Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Nle-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys
NA
NA
Cys1-Cys16; Cys8-Cys20; Cys15-Cys25
25
Linear
NA
Chemically synthesized
NA
NA
NA
BMEC
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Permeability coefficient
0.00001083 cm/s
NA
10822104
b3pdb_1121
Neuromedin U
YKVNEYQGPVAPSGGFFLFRPRN
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn
NA
NA
NA
25
Linear
NA
bacterial
NA
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.0112 min-1
Direct iodination
27040796
b3pdb_1122
Neuromedin U
YKVNEYQGPVAPSGGFFLFRPRN
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn
NA
NA
NA
25
Linear
NA
bacterial
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
83%
Direct iodination
27040796
b3pdb_1123
Neuromedin U
YKVNEYQGPVAPSGGFFLFRPRN
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn
NA
NA
NA
25
Linear
NA
bacterial
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
17%
Direct iodination
27040796
b3pdb_1124
Neuromedin U
YKVNEYQGPVAPSGGFFLFRPRN
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn
NA
NA
NA
25
Linear
NA
bacterial
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00131 mL/(g x min)
Direct iodination
27040796
b3pdb_1160
PepH4
KSKAINVLRGFRKEIGRMLNILN
LysSerLysAlaIleAsnValLeuArgGlyPheArgLysGluIleGlyArgMetLeuAsnIleLeuAsn
NA
NA
NA
23
Linear
NA
viral
NA
NA
NA
Initial concentration in donor chamber-Culture
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Translocated
63.45%
63.45%
28263555
b3pdb_1178
D3D3
RPRTRLHTHRNRRPRTRLHTHRNR
Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Hemoglobin
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Brain to plasma ratio
0.6
H3/C14
27086111
b3pdb_1179
RD2D3
PTLHTHNRRRRRRPRTRLHTHRNR
Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Brain to plasma ratio
0.6
H3/C14
27086111
b3pdb_1180
RD2D3
PTLHTHNRRRRRRPRTRLHTHRNR
Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Peak response
0.3 µL/(g x min)
H3/C14
27086111
b3pdb_1181
RD2D3
PTLHTHNRRRRRRPRTRLHTHRNR
Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0003 ml/(g x min)
H3/C14
27086111
b3pdb_1182
RD2D3
PTLHTHNRRRRRRPRTRLHTHRNR
Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0512 ml/g
H3/C14
27086111
b3pdb_1183
cRD2D3
PTLHTHNRRRRRRPRTRLHTHRNR
Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Peak response
2 µL/(g x min)
H3/C14
29225107
b3pdb_1184
cRD2D3
PTLHTHNRRRRRRPRTRLHTHRNR
Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.002 ml/(g x min)
H3/C14
29225107
b3pdb_1185
cRD2D3
PTLHTHNRRRRRRPRTRLHTHRNR
Pro-Thr-Leu-His-Thr-His-Asn-Arg-Arg-Arg-Arg-Arg-Arg-Pro-Arg-Thr-Arg-Leu-His-Thr-His-Arg-Asn-Arg
NA
NA
NA
24
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.1955 ml/g
H3/C14
29225107
b3pdb_1200
tANK6
RKRIRLVTKKKRRKRIRLVTKKKR
Arg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg-Arg-Lys-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg
NA
NA
NA
24
Linear
NA
mouse
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Peak response
1.6 µL/(g x min)
H3/C14
29966196
b3pdb_1201
tANK6
RKRIRLVTKKKRRKRIRLVTKKKR
Arg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg-Arg-Lys-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg
NA
NA
NA
24
Linear
NA
mouse
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0016 mL/(g x min)
H3/C14
29966196
b3pdb_1202
tANK6
RKRIRLVTKKKRRKRIRLVTKKKR
Arg-Lys-Arg-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg-Arg-Lys-Ile-Arg-Leu-Val-Thr-Lys-Lys-Lys-Arg
NA
NA
NA
24
Linear
NA
mouse
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.5833 ml/g
H3/C14
29966196
b3pdb_1218
dNP2
KIKKVKKKGRKGSKIKKVKKKGRK
NA
NA
NA
NA
24
NA
Cationic
Chemically synthesized
NA
Jurkat cells
2 μM
Confocal microscopy
dNP2 enables the delivery of LRR domain of NLRX1 into T cells
C57BL/6J Mice
NA
Intraperitoneal
Confocal microscopy
dNP2 enables the delivery of LRR domain of NLRX1 into T cells
It directly inhibits the functions of effector T cells and ameliorates disease severity of EAE with
NA
NA
Combined with LRR
Encephalomyelitis
NA
NA
NA
32194859
previous
1
2
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD